HLA DR4 and giant cell arteritisBIGNON, J. D; BARRIER, J; SOULILLOU, J. P et al.Tissue antigens. 1984, Vol 24, Num 1, pp 60-62, issn 0001-2815Article

The HLA-DR4 family of haplotypes consists of a series of distinct DR and DS moleculesNEPOM, G. T; NEPOM, B. S; ANTONELLI, P et al.The Journal of experimental medicine. 1984, Vol 159, Num 2, pp 394-404, issn 0022-1007Article

EVALUATION OF DR ANTIGENS IN BLOOD DONORS IN THE WARSAW REGIONWOJTULEWICZ KURBUS J; ZUPANSKA B; PODOBINSKA I et al.1981; ARCH. IMMUNOL. THER. EXP.; ISSN 0004-069X; POL; DA. 1981; VOL. 29; NO 4; PP. 443-445; BIBL. 10 REF.Article

PRELIMINARY EVALUATION OF DR ANTIGENS IN RESPONDERS AND NONRESPONDERS TO ANTIGEN D FROM THE RH BLOOD GROUP SYSTEMWOJTULEWICZ KURKUS J; ZUPANSKA B; PODOBINSKA I et al.1981; ARCH. IMMUNOL. THER. EXP.; ISSN 0004-069X; POL; DA. 1981; VOL. 29; NO 4; PP. 447-450; BIBL. 18 REF.Article

Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5KRATZ, L. E; BOUGHMAN, J. A; NEEDLEMAN, B. W et al.Disease markers. 1989, Vol 7, Num 4, pp 209-213, issn 0278-0240, 5 p.Article

Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell lineDEMARS, R; CHANG, C. C; RUDERSDORF, R. A et al.Human immunology. 1983, Vol 8, Num 2, pp 123-139, issn 0198-8859Article

The prevalence of HLA-DR 4 and HLA-DR 3 in healthy persons with rheumatoid factorGRAN, J. T; HUSBY, G; THORSBY, E et al.Scandinavian journal of rheumatology. 1985, Vol 14, Num 1, pp 79-82, issn 0300-9742Article

Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression = Distribution de l'antigène Leu-10 (HLA-DC/DS) dans les affections leucémiques humaines, détecté par un anticorps monoclonal: corrélation avec l'expression de HLA-DRAYAD AL-KATIB; KOZINER, B.British journal of haematology. 1984, Vol 57, Num 3, pp 373-382, issn 0007-1048Article

HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritisSINGAL, D. R; REID, B; KASSAM, Y. B et al.Lancet (British edition). 1987, Vol 2, Num 8568, pp 1118-1120, issn 0140-6736Article

Association between susceptibility to pre-eclampsia within families and HLA DR4KILPATRICK, D. C; GIBSON, F; LISTON, W. A et al.Lancet (British edition). 1989, Vol 2, Num 8671, pp 1063-1065, issn 0140-6736, 3 p.Article

Heterogeneity of HLA-DRS: definition of two subtypes by the primed lymphocyte testSINGAL, D. P; D'SOUZA, M; BUTLER, L et al.Tissue antigens. 1985, Vol 26, Num 3, pp 172-178, issn 0001-2815Article

GENETIC AND STRUCTURAL ORGANIZATION OF MURINE IA AND HUMAN DR ANTIGENSSILVER J.1981; C.R.C. CRIT. REV. IMMUNOL.; USA; DA. 1981; VOL. 2; NO 3; PP. 225-257; BIBL. 84 REF.Article

HLA-DR ANTIGENS RENDER INTERLEUKIN-2-PRODUCER T LYMPHOCYTES SENSITIVE TO INTERLEUKIN-1PALACIOS R.1981; SCAND. J. IMMUNOL.; ISSN 0300-9475; NOR; DA. 1981; VOL. 14; NO 3; PP. 321-326; BIBL. 16 REF.Article

HLA-DR antigen expression in primary melanomas of the skinBROCKER, E.-B; SUTER, L; SORG, C et al.Journal of investigative dermatology. 1984, Vol 82, Num 3, pp 244-247, issn 0022-202XArticle

Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritisNEPOM, B. S; NEPOM, G. T; MICKELSON, E et al.The Journal of clinical investigation. 1984, Vol 74, Num 1, pp 287-291, issn 0021-9738Article

Increase of HLA-DRw6 in patients with juvenile chronic arthritisREEKERS, P; SCHRETLEN, E. D. A. M; VAN DE PUTTE, L. B. A et al.Tissue antigens. 1983, Vol 22, Num 4, pp 283-288, issn 0001-2815Article

A method to facilitate the reading of up to 60 samples of monoclonal antibody fluorescence stained cells using medicell HLA-DR platesSENSI, M; POZZILLI, P; DI MARIO, U et al.Journal of clinical & laboratory immunology. 1984, Vol 13, Num 2, pp 101-102, issn 0141-2760Article

Definition of a new DR2 short associated HLA-D specificity with the ninth histocompatibility workshop reagentsCOHEN, N; AMAR, A; BRAUTBAR, C et al.Tissue antigens. 1984, Vol 24, Num 3, pp 184-186, issn 0001-2815Article

Insulin autoimmune syndrome and LHA-DR4SPINAS, G. A; KELLER, U.Lancet (British edition). 1992, Vol 339, Num 8808, issn 0140-6736, p. 1549Article

Class II MHC antigen (HLA-DR3) predisposes to sarcoid arthritisKRAUSE, A; GOEBEL, K. M.Journal of clinical & laboratory immunology. 1987, Vol 24, Num 1, pp 25-27, issn 0141-2760Article

Expression of HLA-DR (Ia like) antigen on epidermal keratinocytes in human dermatosesLAMPERT, I. A.Clinical and experimental immunology (Print). 1984, Vol 57, Num 1, pp 93-100, issn 0009-9104Article

Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potencySZEWCZUK, Zbigniew; BIERNAT, Monika; DYBA, Marcin et al.Peptides (New York, NY. 1980). 2004, Vol 25, Num 2, pp 207-215, issn 0196-9781, 9 p.Article

HLA-DR-antigen bearing keratinocytes in various dermatologic disordersSMOLLE, J.Acta dermato-venereologica. 1985, Vol 65, Num 1, pp 9-13, issn 0001-5555Article

Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate = Expression différentielle des molécules HLA-DR et HLA-DC/DS chez un malade atteint de tricholeucémie: restauration de l'expression HLA-DC/DS par (12-0-tétradécanoyl phorbol-13-acétate), 5 azacytidine et butyrate de sodiumFAILLE, A; TURMEL, P; CHARRON, D. J et al.Blood. 1984, Vol 64, Num 1, pp 33-37, issn 0006-4971Article

Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblastsORGAD, S; YUNIS, E. J; ZAIZOV, R et al.Human immunology. 1984, Vol 9, Num 2, pp 67-74, issn 0198-8859Article